Schonfeld Strategic Advisors LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 216 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$48,080
-83.4%
107,687
-42.1%
0.00%
-100.0%
Q4 2022$290,115
-40.7%
185,971
-34.4%
0.00%
-50.0%
Q3 2022$489,000
+129.6%
283,529
+130.7%
0.00%
+100.0%
Q2 2022$213,000
+432.5%
122,902
+1017.3%
0.00%
Q1 2022$40,000
-78.6%
11,000
-70.7%
0.00%
-100.0%
Q4 2021$187,000
+14.7%
37,500
+64.5%
0.00%0.0%
Q3 2021$163,000
-68.2%
22,800
-58.8%
0.00%
-60.0%
Q2 2021$513,000
-45.5%
55,351
-48.0%
0.01%
-61.5%
Q4 2020$942,000
+698.3%
106,443
+949.3%
0.01%
+550.0%
Q3 2020$118,00010,1440.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders